You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

PROCHLORPERAZINE - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for prochlorperazine and what is the scope of freedom to operate?

Prochlorperazine is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Padagis Us, Able, Cosette, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Watson Labs, Wyeth Ayerst, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva Pharms, Zydus, and Jubilant Cadista, and is included in fifty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for prochlorperazine. Three suppliers are listed for this compound.

Summary for PROCHLORPERAZINE

US Patents:	0
Tradenames:	6
Applicants:	33
NDAs:	52
Drug Master File Entries:	21
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	57
Clinical Trials:	48
Patent Applications:	6,784
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for PROCHLORPERAZINE
Drug Sales Revenues:	Drug sales revenues for PROCHLORPERAZINE
What excipients (inactive ingredients) are in PROCHLORPERAZINE?	PROCHLORPERAZINE excipients list
DailyMed Link:	PROCHLORPERAZINE at DailyMed

See drug prices for PROCHLORPERAZINE

Drug Sales Revenue Trends for PROCHLORPERAZINE

See drug sales revenues for PROCHLORPERAZINE

Recent Clinical Trials for PROCHLORPERAZINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Calgary	Phase 3
Ehsan Malek	Early Phase 1
New York State Psychiatric Institute	Phase 2

See all PROCHLORPERAZINE clinical trials

Pharmacology for PROCHLORPERAZINE

Drug Class	Phenothiazine

Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE

Antiemetics
Antipsychotic Agents
Dopamine Antagonists

US Patents and Regulatory Information for PROCHLORPERAZINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	COMPAZINE	prochlorperazine edisylate	INJECTABLE;INJECTION	010742-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Ayerst	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	086348-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glaxosmithkline	COMPAZINE	prochlorperazine maleate	CAPSULE, EXTENDED RELEASE;ORAL	011000-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Duramed Pharms Barr	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	089486-001	Jan 20, 1987		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Duramed Pharms Barr	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	040207-002	May 1, 1997		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hospira	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	089703-001	Apr 7, 1988		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.